Article
Novel molecular insights and potential approaches for targeting hypertrophic cardiomyopathy: Focus on coronary modulators.
Vascular pharmacology - 1 Aug 2022
Pasqua Teresa, Tropea Teresa, Granieri Maria Concetta, De Bartolo Anna, Spena Angela, Moccia Francesco, Rocca Carmine, Angelone Tommaso
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disorder that associates with nucleotide sequence variants in genes encoding sarcomere related proteins, and is recognized as the most common heritable cardiac diseases. Clinically, HCM can be extremely variable and this makes the diagnosis difficult until the development of serious or fatal events. Nevertheless, the main hallmark of HCM is represented by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
